SLN - Silence Therapeutics PLC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SLN is currently covered by 1 analysts

Silence Therapeutics PLC's activity chart (see below) currently has 45 price targets and 62 ratings on display. The stock rating distribution of SLN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.21% with an average time for these price targets to be met of 147.4 days.

Highest price target for SLN is $7, Lowest price target is $5.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 13-Mar-2026. First documented stock forecast 24-Aug-2020.

Best performing analysts who are covering SLN - Silence Therapeutics PLC:

Keay Nakae Michael Ulz Patrick Trucchio Thomas Shrader Richard Law

Currently out of the existing stock ratings of SLN, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Aug-2020

4 months 23 days ago
(13-Mar-2026)

1/13 (7.69%)

$70.15 (1446.39%)

77

Buy Since 31-Mar-2022

1 years 1 months 23 days ago
(13-Jun-2025)

2/6 (33.33%)

$39.31 (250.54%)

277

Buy Since 08-May-2023

$25

$18.9 (309.84%)

1 years 2 months 27 days ago
(09-May-2025)

6/12 (50%)

$21.3 (575.68%)

223

Sell Since 10-Feb-2025

$3

$-3.1 (-50.82%)

1 years 2 months 27 days ago
(09-May-2025)

1/2 (50%)

$-0.7 (-18.92%)

133

Buy Since 18-Nov-2020

$15

$9.27 (161.78%)

$32

2 years 8 months 21 days ago
(15-Nov-2023)

1/2 (50%)

$5.58 (59.24%)

27

Show more analysts

Please expand the browser size to see the chart

What is SLN (Silence Therapeutics PLC) average time for price targets to be met?

On average it took 147.4 days on average for the stock forecasts to be realized with a an average price target met ratio 38.21

Which analyst has the current highest performing score on SLN (Silence Therapeutics PLC) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on SLN (Silence Therapeutics PLC) with a proven track record?

RICHARD LAW

Which analyst has the most public recommendations on SLN (Silence Therapeutics PLC)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 8 ratings on SLN

Which analyst is the currently most bullish on SLN (Silence Therapeutics PLC)?

Michael Ulz with highest potential upside - $18.9

Which analyst is the currently most reserved on SLN (Silence Therapeutics PLC)?

Richard Law with lowest potential downside - -$3.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?